BANK VONTOBEL/CALL/ELI LILLY & CO/460/0.1/21.06.24 Share Price

Warrant

DE000VU9JAQ6

Delayed Deutsche Boerse AG 05:21:28 24/05/2024 pm IST
32.94 EUR +1.26% Intraday chart for BANK VONTOBEL/CALL/ELI LILLY & CO/460/0.1/21.06.24
Current month+7.97%
1 month+20.30%
Date Price Change
24/24/24 32.94 +1.26%
23/24/23 32.53 +3.04%
22/24/22 31.57 -2.17%
21/24/21 32.27 +7.42%
20/24/20 30.04 +3.44%

Delayed Quote Deutsche Boerse AG

Last update May 24, 2024 at 05:21 pm IST

More quotes

Static data

Product typeWarrants
Buy / SellCALL
Underlying ELI LILLY AND COMPANY
IssuerLogo Issuer Vontobel Vontobel
WKN VU9JAQ
ISINDE000VU9JAQ6
Date issued 05/07/2023
Strike 460 $
Maturity 21/06/2024 (28 Days)
Parity 10 : 1
Emission price 5.52
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 32.94
Lowest since issue 3.91
Delta0.95x
Omega 2.128
Premium1.34x
Gearing2.25x
Moneyness 1.758
Difference Strike -348.5 $
Difference Strike %-75.75%
Spread 0.21
Spread %0.63%
Intrinsic value 32.14

Company Profile

Eli Lilly and Company is one of the world's leading pharmaceutical groups. Net sales break down by therapeutic field as follows: - endocrinology (57.7%): products for treating osteoporosis, diabetes, and growth problems; - oncology (19.5%); - immunology diseases (11.1%); - neurology (8.4%): primarily drugs used in treating depression and schizophrenia; - other (3.3%). Net sales are distributed geographically as follows: the United States (63.9%), Europe (18.1%), Japan (4.9%), China (4.5%) and other (8.6%).
Sector
-
More about the company

Ratings for Eli Lilly and Company

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Eli Lilly and Company

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
808.4 USD
Average target price
850.8 USD
Spread / Average Target
+5.24%
Consensus